p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. [electronic resource]
Producer: 19941202Description: 5824-30 p. digitalISSN:- 0008-5472
- Apoptosis -- genetics
- Burkitt Lymphoma -- genetics
- Cisplatin -- pharmacology
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins -- metabolism
- DNA Topoisomerases, Type II -- analysis
- Drug Resistance -- genetics
- Etoposide -- pharmacology
- Flow Cytometry
- G1 Phase -- drug effects
- Gamma Rays
- Genes, p53 -- genetics
- Humans
- Lymphocytes
- Mechlorethamine -- pharmacology
- Mutation -- genetics
- Nocodazole -- pharmacology
- RNA, Messenger -- analysis
- Radiation Tolerance -- genetics
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.